Leuprorelin 99% Cas No.53714-56-0

Peb muab siab -purity Leuprorelin Active Pharmaceutical Ingredient (API), tsim nyob rau hauv kev tswj xyuas nruj kom ua tau raws li qhov xav tau ntawm kev tsim tshuaj thiab kev tsim khoom. Peb cov khoom yog tus cwj pwm los ntawm nws qib purity siab (Ntau dua lossis sib npaug li 99%) thiab zoo ib yam, kom ntseeg tau tias nws yog qhov tsim nyog rau koj qhov kev nruj ua ntej- kev tshawb fawb thiab kev tsim ua haujlwm.

Txhawm rau txhawb koj cov haujlwm ntawm txhua qhov teev, peb muab cov kev xaiv ntim tau yooj yim txij li milligrams mus rau kilograms. Raws li koj tus khub uas ntseeg siab, peb tau cog lus los muab qhov kev cog lus peptide API no, txhawb koj txoj kev txhim kho tshuaj tshiab nrog kev ntseeg siab thiab siab - cov ntaub ntawv zoo.

Leuprorelin yog ib qho muaj zog hluavtaws analog ntawm Gonadotropin -Tshuaj Hormone (GnRH). Nws cov tshuaj pharmacological ua rau pom cov nyhuv biphasic ib txwm:

• Pib Stimulatory Phase: Thaum pib thawj zaug, nws ua rau lub caj pas anterior pituitary tso tawm Luteinizing Hormone (LH) thiab Follicle-Stimulating Hormone (FSH), ua rau muaj kev hloov pauv hauv cov tshuaj hormones (testosterone, estrogen) qib.

• Sustained Suppressive Phase: Nrog rau kev tswj xyuas tas mus li, nws sai sai ua rau qis qis - kev tswj hwm ntawm GnRH receptors hauv qog pituitary. Qhov no inhibits qhov tso tawm ntawm LH thiab FSH, thaum kawg txo qis kev sib deev hormone tsim los ntawm gonads mus rau castration theem. Cov nyhuv inhibitory no thim rov qab thaum txiav kev kho mob.

Raws li cov tshuaj nonapeptide, Leuprorelin ua los ntawm kev khi nrog kev sib raug zoo siab rau GnRH receptors ntawm daim nyias nyias ntawm pituitary gonadotrope hlwb. Vim nws qhov kev tiv thaiv ntau dua rau enzymatic degradation piv rau haiv neeg GnRH, nws nyob hauv vivo ib nrab - lub neej yog ntev heev. Kev ua haujlwm tsis tu ncua ua rau cuam tshuam rau lub cev pulsatile signaling ntawm endogenous GnRH, ua rau receptor desensitization thiab internalization. Qhov no cuam tshuam cov hypothalamic{4}}pituitary-gonadal (HPG) axis, uas ua rau muaj kev cuam tshuam ntawm kev sib deev hormone synthesis thiab secretion.

Thaum tsim tawm rau hauv cov ntaub ntawv tsim nyog, Leuprorelin API yog npaj los xa cov teebmeem hauv qab no:

• Ua kom txo tau cov qib tshuaj hormones hauv kev sib deev: Ib txwm ua rau cov ntshav testosterone hauv cov txiv neej thiab cov ntshav estradiol hauv cov poj niam kom castrate ntau yam.

• Inhibits kev loj hlob ntawm lub hom phiaj cov ntaub so ntswg: inhibits kev loj hlob thiab kev loj hlob ntawm cov tshuaj hormones-nyob ntawm cov qog thiab cov ntaub so ntswg pathological los ntawm depriving lawv ntawm qhov tsim nyog hormonal ib puag ncig.

Qhov no siab -purity active tshuaj muaj nyob rau hauv cov chaw tsim tshuaj feem ntau rau kev loj hlob thiab zus tau tej cov tshuaj nyob rau hauv cov nram qab no qhov chaw:

• Oncology:

◦ Palliative kho mob cancer prostate siab heev.

◦ Kev tswj mob qog noj ntshav, tshwj xeeb tshaj yog nyob rau hauv cov tshuaj hormone receptor- cov poj niam premenopausal thiab perimenopausal zoo.

• Gynecological Disorders:

◦ Cov tsos mob nyem (xws li, txo qhov mob) hauv endometriosis.

◦ Ua ntej-kev kho mob ntawm uterine fibroids (leiomyomas) kom txo cov fibroid loj thiab tswj cov ntshav qab zib.

• Central Precocious Puberty: Siv los tiv thaiv qhov pib ntxov ntxov ntawm kev laus laus hauv cov menyuam yaus.

Cov ntaub ntawv saum toj no yog ua raws li kev tshawb fawb tshawb fawb thiab cov ntaub ntawv kho mob pej xeem thiab tsuas yog siv rau kev siv xwb. Cov khoom no yog Active Pharmaceutical Ingredient (API) tsuas yog siv los ntawm cov kws tshaj lij hauv kev tshawb fawb tshuaj, kev tsim kho, thiab kev tsim khoom. Nws yog txwv tsis pub siv ncaj qha rau tib neeg lossis kev tswj hwm raws li cov tshuaj tiav.

Cim npe nrov: leuprorelin 99% cas no.53714-56-0, Tuam Tshoj leuprorelin 99% cas no.53714-56-0 manufacturers, lwm tus neeg, Hoobkas